Intestinal Research (Oct 2020)
Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
- Ajit Sood,
- Vineet Ahuja,
- Vandana Midha,
- Saroj Kant Sinha,
- C. Ganesh Pai,
- Saurabh Kedia,
- Varun Mehta,
- Sawan Bopanna,
- Philip Abraham,
- Rupa Banerjee,
- Shobna Bhatia,
- Karmabir Chakravartty,
- Sunil Dadhich,
- Devendra Desai,
- Manisha Dwivedi,
- Bhabhadev Goswami,
- Kirandeep Kaur,
- Rajeev Khosla,
- Ajay Kumar,
- Ramit Mahajan,
- S. P. Misra,
- Kiran Peddi,
- Shivaram Prasad Singh,
- Arshdeep Singh
Affiliations
- Ajit Sood
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India
- Vineet Ahuja
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
- Vandana Midha
- Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, India
- Saroj Kant Sinha
- Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
- C. Ganesh Pai
- Department of Gastroenterology, Kasturba Medical College, Manipal, India
- Saurabh Kedia
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India
- Varun Mehta
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India
- Sawan Bopanna
- Fortis Hospital, New Delhi, India
- Philip Abraham
- P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India
- Rupa Banerjee
- Asian Institute of Gastroenterology, Hyderabad, India
- Shobna Bhatia
- Department of Gastroenterology, King Edward Memorial Hospital, Mumbai, India
- Karmabir Chakravartty
- Department of Gastroenterology, AMRI Hospital, Kolkata, India
- Sunil Dadhich
- Department of Gastroenterology, Dr. Sampurnanand Medical College, Jodhpur, India
- Devendra Desai
- P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India
- Manisha Dwivedi
- Department of Gastroenterology, Moti Lal Nehru Medical College, Allahabad, India
- Bhabhadev Goswami
- Department of Gastroenterology, Gauhati Medical College, Guwahati, India
- Kirandeep Kaur
- Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, India
- Rajeev Khosla
- Max Super Speciality Hospital, Saket, New Delhi, India
- Ajay Kumar
- BLK Super Speciality Hospital, New Delhi, India
- Ramit Mahajan
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India
- S. P. Misra
- Department of Gastroenterology, Moti Lal Nehru Medical College, Allahabad, India
- Kiran Peddi
- Citizens Centre for Digestive Disorders, Hyderabad, India
- Shivaram Prasad Singh
- Department of Gastroenterology, Sriram Chandra Bhanj Medical College and Hospital, Cuttack, India
- Arshdeep Singh
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India
- DOI
- https://doi.org/10.5217/ir.2019.09176
- Journal volume & issue
-
Vol. 18,
no. 4
pp. 355 – 378
Abstract
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through a modified Delphi process, and includes guiding statements and recommendations based on literature evidence (randomized trials, and observational studies), clinical practice, and expert opinion on use of 5-ASA in IBD by Indian gastroenterologists. The aim is to aid practitioners in selecting appropriate treatment strategies and facilitate optimal use of 5-ASA in patients with IBD.
Keywords
